Paliperidone Extended Release (ER) [clinicaltrials_resource:NCT00757705/group/B1]
Participants received flexible dose of 3 to 12 milligram (mg) of paliperidone ER once daily orally for 24 weeks. Dose adjustment was done as per Investigator’s discretion based upon participant’s clinical response to and tolerability of the study drug.
group [clinicaltrials_vocabulary:group]
NCT00757705 measurement [clinicaltrials_resource:NCT00757705/measurement/0beac56380d164453ca76cdc14bd0310]NCT00757705 measurement [clinicaltrials_resource:NCT00757705/measurement/34f699c6d009215945ecff17a4b7d5db]NCT00757705 measurement [clinicaltrials_resource:NCT00757705/measurement/400ae8b64352ed1c01eef537235be94d]NCT00757705 measurement [clinicaltrials_resource:NCT00757705/measurement/6d7b518592865cc12358fb8e1a53997b]
group id [clinicaltrials_vocabulary:group-id]
Paliperidone Extended Release (ER) [clinicaltrials_resource:NCT00757705/group/B1]
Participants received flexible dose of 3 to 12 milligram (mg) of paliperidone ER once daily orally for 24 weeks. Dose adjustment was done as per Investigator’s discretion based upon participant’s clinical response to and tolerability of the study drug.
Bio2RDF identifier
NCT00757705/group/B1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00757705/group/B1
group id [clinicaltrials_vocabulary:group-id]
description
Participants received flexible ...... olerability of the study drug.
@en
identifier
clinicaltrials_resource:NCT00757705/group/B1
title
Paliperidone Extended Release (ER)
@en
type
label
Paliperidone Extended Release (ER) [clinicaltrials_resource:NCT00757705/group/B1]
@en